Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis for use in the life sciences and clinical healthcare markets. It offers GeneChip system and related microarray technology platform for acquiring, analyzing, and managing genetic information. The company's GeneChip microarray platform includes disposable DNA probe arrays containing genetic information on a chip; reagents for extracting, amplifying, and labeling target nucleic acids; a fluidics station for introducing the test sample to the probe arrays; a hybridization oven for optimizing the binding of samples to the probe arrays; a scanner to read the fluorescent image from the probe arrays; and software to analyze and manage the resulting genetic information. It also offers related microarray technology that includes instrumentation, software, and licenses for fabricating, scanning, collecting, and analyzing results from low density microarrays. In addition, the company markets CustomExpress, CustomSeq, and NimbleExpress products that enable its customers to design their own custom GeneChip expression arrays or sequence arrays for organisms of interest to them. Affymetrix sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, industrial, and consumer products companies, as well as to academic research centers, government research laboratories, private foundation laboratories, and clinical reference laboratories in North America and Europe. The company also offers its products in Latin America, India, the Middle East, and Asia Pacific regions, including China through distributors. It has collaboration agreements with Qiagen, GmbH; PreAnalytiX GmbH; Perlegen Sciences, Inc.; bioM?rieux, Inc.; F. Hoffmann-La Roche Ltd.; Veridex, LLC.; Sysmex Corporation; Caliper Life Sciences, Inc.; Caliper Life Sciences, Inc.; and IPSOGEN. The company was founded in 1991 and is headquartered in Santa Clara, California.